NEW YORK (GenomeWeb News) – Veracyte said after the close of the market on Monday that revenues in its third quarter improved 75 percent year over year.

The South San Francisco, Calif.-based company, which went public earlier this month, raising $58 million in net proceeds, reported revenues of $5.6 million for the three months ended Sept. 30, up from $3.2 million in the year-ago period.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.